1. Home
  2. HUM vs IQV Comparison

HUM vs IQV Comparison

Compare HUM & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humana Inc.

HUM

Humana Inc.

SELL

Current Price

$457.54

Market Cap

50.1B

Sector

Health Care

ML Signal

SELL

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

SELL

Current Price

$265.45

Market Cap

43.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HUM
IQV
Founded
1961
1982
Country
United States
United States
Employees
N/A
93000
Industry
Medical Specialities
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.1B
43.1B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
HUM
IQV
Price
$457.54
$265.45
Analyst Decision
Buy
Strong Buy
Analyst Count
26
20
Target Price
★ $494.25
$311.89
AVG Volume (30 Days)
1.1M
★ 1.2M
Earning Date
11-06-2026
10-27-2026
Dividend Yield
★ 0.79%
N/A
EPS Growth
N/A
★ 4.67
EPS
★ 16.84
5.24
Revenue
★ $129,664,000,000.00
$9,739,000,000.00
Revenue This Year
$25.64
$7.18
Revenue Next Year
$5.94
$6.34
P/E Ratio
★ $26.64
$50.84
Revenue Growth
10.11
★ 41.60
52 Week Low
$163.11
$154.50
52 Week High
$456.50
$284.50

Technical Indicators

Market Signals
Indicator
HUM
IQV
Relative Strength Index (RSI) 65.62 46.99
Support Level $397.36 $252.49
Resistance Level N/A $274.49
Average True Range (ATR) 17.54 9.24
MACD 3.04 -0.63
Stochastic Oscillator 95.34 44.74

Price Performance

Historical Comparison
HUM
IQV

About HUM Humana Inc.

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: